EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appoint

EQSAdhoc MorphoSys AG Key word Personnel Ad hoc Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO 06Jun2024 2219 CETCEST Disclosure of

Related Keywords

Boston , Massachusetts , United States , Planegg , Bayern , Germany , Munich , Arkadius Pichota , Lukas Gilgen , Krisja Vermeylen , George Golumbeski , Julia Neugebauer , Heinrich Moisa , Silke Mainka , Marc Cluzel , Andrew Cheng , Jean Paul Kress , Michael Brosnan , Lucinda Crabtree , Biopharma Services Inc , Company Management Board , Novartis , Nasdaq , Distribution Services , Exchange Commission , Munich Local Court , Novartis International , Twitter , Linkedin , Management Board , Novartis Bidco , Romain Lege , Supervisory Board , General Manager , Navigate Biopharma Services , Transaction Lead Enterprise Projects , Paul Kress , Rating Morphosys , Morphosy Annual Report , Recommendation Statement , Global Head , Regulatory Announcements , Corporate News ,